• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

786-300-3183 | [email protected]

  • Twitter
  • Facebook
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • FSA Past Presidents
      • Distinguished Service Award Past Recipients
      • Recipients of the FSA Presidential Engagement Award
    • FSA Staff
    • FSA NEWS
    • Calendar of Events
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • FSA Annual Meeting
    • 2025 Annual Meeting
    • 2024 Annual Meeting Recap
    • Call For Abstracts
    • Past Posters
      • 2025 FSA Podium and Poster Abstracts
      • 2024 FSA Podium and Poster Abstracts
      • 2023 FSA Podium and Poster Abstracts
      • 2022 FSA Podium and Poster Abstracts
      • 2021 FSA Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
    • Past Meetings
      • 2023 Meeting Recap
      • 2022 Annual Meeting Recap
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
  • FSAPAC
    • Donate to the FSAPAC
    • FSAPAC Donors for 2025
  • Member Login
  • Member Portal
  • Become a Member
    • FSA Membership Renewal
    • Join the Florida Society of Anesthesiologists (FSA)

2020 FSA Posters

2020 FSA Posters

P048: CARDIOVASCULAR OUTCOME IN ELDERLY PATIENTS WITH EF<55% PRESENTING FOR LIVER TRANSPLANT: CASE SERIES
Mohammad Z Khan, MD; Shashidhar Manchegowda, MD; Rofayda Gad, MD; Nathalia Torres Buendia, MD; Ramona Nicolau-Raducu, MD; Fouad G Souki, MD; Jackson Memorial Hospital

Introduction: Nowadays, patients undergoing liver transplantation are more likely to be older with cardiac comorbidities. There is limited data about major adverse cardiovascular events (MACE) (myocardial infarction, heart failure (HF), arrhythmias, stroke, pulmonary embolism) and outcome in patients with decreased cardiac contractility presenting for liver transplantation. We present cardiovascular outcomes in a case series of five patients with LVEF<55% who underwent liver transplantation.

Methods: Following institutional review board approval, we reviewed liver and combined liver-kidney transplant casesin patients ≥18 years old performed from January 2016 to December 2018 at University of Miami/Jackson Memorial Hospital. Out of 287 records,five patients met the inclusion criteria of LV EF< 55% pretransplant. Perioperative data wasobtained by retrospective review of electronic medical records.

Results: Patients with EF<55% were all elderly (age 63-76). MACE (MI/stroke/heart failure/arrhythmia) was noted in 4 out of 5 patients (Table 1). Postoperative atrial fibrillation occurred in two patients while heart failure occurred in 3 out of 5 patients. HF was due to ischemic (2) and nonischemic (1) causes. Two out of three patients with preoperative CAD >50% had ischemic heart failure postoperatively. One patient had a severe decrease in EF (15%), which showed no improvement even three months after surgery. Intraoperatively, he had severe reperfusion syndrome and hepatic artery thrombosis, and post operatively, he developed stress induced cardiomyopathy and had a long hospital stay. Despite MACE, there was no mortality or graft failure 1 year postoperatively. All patients had low MELD, short operative time, and minimal blood transfusion (PRBC 3-8 units).None of the patients had pre transplant hospitalization.

Conclusion: Patients with preoperative decrease cardiac function (EF<55%) are more likely to be elderly with preoperative ischemic disease. These patients are at higher risk of MACE postoperatively.Careful cardiovascular optimization, adequate patient selection, and favorable operative variables can lead to good postoperative outcome.

Copyright © 2025 · Florida Society of Anesthesiologists · All Rights Reserved